BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12446599)

  • 1. Double mutations in klotho and osteoprotegerin gene loci rescued osteopetrotic phenotype.
    Yamashita T; Okada S; Higashio K; Nabeshima Y; Noda M
    Endocrinology; 2002 Dec; 143(12):4711-7. PubMed ID: 12446599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retardation in bone resorption after bone marrow ablation in klotho mutant mice.
    Yamashita T; Yoshitake H; Tsuji K; Kawaguchi N; Nabeshima Y; Noda M
    Endocrinology; 2000 Jan; 141(1):438-45. PubMed ID: 10614667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
    Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klotho-deficient mice are resistant to bone loss induced by unloading due to sciatic neurectomy.
    Yamashita T; Sekiya I; Kawaguchi N; Kashimada K; Nifuji A; Nabeshima YI; Noda M
    J Endocrinol; 2001 Feb; 168(2):347-51. PubMed ID: 11182773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype.
    Varga F; Spitzer S; Klaushofer K
    Calcif Tissue Int; 2004 Apr; 74(4):382-7. PubMed ID: 15255076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.
    Ma YL; Cain RL; Halladay DL; Yang X; Zeng Q; Miles RR; Chandrasekhar S; Martin TJ; Onyia JE
    Endocrinology; 2001 Sep; 142(9):4047-54. PubMed ID: 11517184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution micro-computed tomography analyses of the abnormal trabecular bone structures in klotho gene mutant mice.
    Yamashita T; Nabeshima Y; Noda M
    J Endocrinol; 2000 Feb; 164(2):239-45. PubMed ID: 10657859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated.
    Gori F; Hofbauer LC; Dunstan CR; Spelsberg TC; Khosla S; Riggs BL
    Endocrinology; 2000 Dec; 141(12):4768-76. PubMed ID: 11108292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
    Lee SK; Lorenzo JA
    Endocrinology; 1999 Aug; 140(8):3552-61. PubMed ID: 10433211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44.
    Cao JJ; Singleton PA; Majumdar S; Boudignon B; Burghardt A; Kurimoto P; Wronski TJ; Bourguignon LY; Halloran BP
    J Bone Miner Res; 2005 Jan; 20(1):30-40. PubMed ID: 15619667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin in the inner ear may inhibit bone remodeling in the otic capsule.
    Zehnder AF; Kristiansen AG; Adams JC; Merchant SN; McKenna MJ
    Laryngoscope; 2005 Jan; 115(1):172-7. PubMed ID: 15630389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor.
    Yamada N; Tsujimura T; Ueda H; Hayashi S; Ohyama H; Okamura H; Terada N
    Cytokine; 2005 Aug; 31(4):288-97. PubMed ID: 15996478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
    Ikeda T; Utsuyama M; Hirokawa K
    J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats.
    Wang FS; Wang CJ; Chen YJ; Huang YT; Huang HC; Chang PR; Sun YC; Yang KD
    Endocrinology; 2004 May; 145(5):2148-56. PubMed ID: 14962990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene.
    Onyia JE; Miles RR; Yang X; Halladay DL; Hale J; Glasebrook A; McClure D; Seno G; Churgay L; Chandrasekhar S; Martin TJ
    J Bone Miner Res; 2000 May; 15(5):863-71. PubMed ID: 10804015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.
    Magal I; Lebel E; Altarescu G; Itzchaki M; Rudensky B; Foldes AJ; Zimran A; Elstein D
    Br J Haematol; 2006 Apr; 133(1):93-7. PubMed ID: 16512834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells.
    Fan X; Roy E; Zhu L; Murphy TC; Ackert-Bicknell C; Hart CM; Rosen C; Nanes MS; Rubin J
    Endocrinology; 2004 Feb; 145(2):751-9. PubMed ID: 14563699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoprotegerin inhibits tumor-induced osteoclastogenesis and bone tumor growth in osteopetrotic mice.
    Clohisy DR; Ramnaraine ML; Scully S; Qi M; Van G; Tan HL; Lacey DL
    J Orthop Res; 2000 Nov; 18(6):967-76. PubMed ID: 11192258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H; Guo J; Bringhurst FR
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.